Astera Labs, Inc. $ALAB Shares Bought by FORA Capital LLC

FORA Capital LLC lifted its stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 20.2% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 33,324 shares of the company’s stock after purchasing an additional 5,602 shares during the quarter. Astera Labs comprises 1.2% of FORA Capital LLC’s portfolio, making the stock its 13th largest position. FORA Capital LLC’s holdings in Astera Labs were worth $6,525,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also made changes to their positions in the company. Assetmark Inc. boosted its position in Astera Labs by 374.1% during the 3rd quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after purchasing an additional 101 shares during the period. Pinpoint Asset Management Singapore Pte. Ltd. acquired a new stake in Astera Labs in the third quarter worth $47,000. Whittier Trust Co. bought a new stake in Astera Labs in the third quarter valued at $55,000. Ramirez Asset Management Inc. bought a new stake in Astera Labs in the third quarter valued at $59,000. Finally, Atlantic Union Bankshares Corp boosted its holdings in shares of Astera Labs by 1,338.1% during the third quarter. Atlantic Union Bankshares Corp now owns 302 shares of the company’s stock valued at $59,000 after acquiring an additional 281 shares during the period. Institutional investors own 60.47% of the company’s stock.

Insiders Place Their Bets

In other Astera Labs news, CFO Michael Truett Tate sold 12,001 shares of the company’s stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total value of $1,485,843.81. Following the completion of the sale, the chief financial officer directly owned 192,083 shares in the company, valued at $23,781,796.23. This represents a 5.88% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Jack R. Lazar sold 7,500 shares of the stock in a transaction on Thursday, March 5th. The shares were sold at an average price of $119.80, for a total value of $898,500.00. Following the transaction, the director directly owned 87,351 shares of the company’s stock, valued at approximately $10,464,649.80. The trade was a 7.91% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 224,292 shares of company stock valued at $27,676,069. 12.50% of the stock is currently owned by insiders.

Astera Labs Stock Up 0.3%

ALAB stock opened at $120.31 on Friday. The company has a 50-day simple moving average of $147.89 and a 200 day simple moving average of $168.18. The company has a market capitalization of $20.48 billion, a P/E ratio of 98.61, a PEG ratio of 2.36 and a beta of 1.74. Astera Labs, Inc. has a fifty-two week low of $47.13 and a fifty-two week high of $262.90.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, beating the consensus estimate of $0.51 by $0.07. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The firm had revenue of $270.58 million for the quarter, compared to analysts’ expectations of $249.46 million. During the same quarter last year, the company earned $0.37 EPS. Astera Labs’s quarterly revenue was up 91.8% on a year-over-year basis. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. Equities analysts anticipate that Astera Labs, Inc. will post 0.34 EPS for the current year.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on ALAB shares. Northland Securities upped their price target on shares of Astera Labs from $175.00 to $195.00 and gave the stock an “outperform” rating in a research report on Tuesday, December 9th. BNP Paribas Exane began coverage on shares of Astera Labs in a research note on Thursday, November 20th. They set an “outperform” rating for the company. Loop Capital started coverage on shares of Astera Labs in a research report on Thursday, March 5th. They issued a “buy” rating and a $250.00 target price for the company. Barclays set a $165.00 price target on shares of Astera Labs in a research note on Thursday, January 15th. Finally, Weiss Ratings cut Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday, February 23rd. Fifteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Astera Labs presently has a consensus rating of “Moderate Buy” and a consensus target price of $202.22.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.